Medical Device-Makers Face Dynamic Commercial Compliance Risks
Erinn Hutchinson, a Philadelphia-based health industries risk consultant with PricewaterhouseCoopers LLP, talked to Medtech Insight about how she advises medical device companies – big and small – trying to market devices in a dynamic legal compliance environment.
You may also be interested in...
The latest government filing in a False Claims Act case involving Coloplast counters the defendants’ argument that the case should be dismissed because the alleged kickbacks fell within the "discount" safe harbor.
Analogic Corp. and its subsidiary BK Medical APS are paying almost $15m to settle allegations that BK conspired with distributors to commit fraud overseas.
The Centers for Medicare and Medicaid Services hasn’t yet cracked down on missing Open Payments submissions, although the agency has financial penalties at its disposal, speakers said during a recent Food and Drug Law Institute webinar. Meanwhile, companies continue to face challenges in maintaining compliance to both federal and state payment disclosure requirements.